Balaji Amines reported Q4FY26 consolidated revenue of ₹403 crore and net profit of ₹65 crore, with EBITDA margins improving to 25%.
The company announced new projects including a DME plant and a ₹750 crore expansion in subsidiary Balaji Speciality Chemicals for cyanide and EDTA products.
Management cited resilience despite a March disruption, maintaining zero debt and focusing on plant utilization and specialty chemicals growth.